Verstraeten R - Search Results

1

Evaluation of colorectal cancer-associated mucin CA M43 assay in serum.

van Kamp GJ, von Mensdorff-Pouilly S, Kenemans P, Verstraeten R, Yedema CA, Wobbes T, Bon GG, Kok A, Brown JP, Hilgers J, et al. van Kamp GJ, et al. Among authors: verstraeten r. Clin Chem. 1993 Jun;39(6):1029-32. Clin Chem. 1993. PMID: 8504532

2

CA 125 serum levels in the early post-operative period do not reflect tumour reduction obtained by cytoreductive surgery.

Yedema CA, Kenemans P, Thomas CM, Massuger LF, Wobbes T, Verstraeten R, van Kamp GJ, Hilgers J. Yedema CA, et al. Among authors: verstraeten r. Eur J Cancer. 1993;29A(7):966-71. doi: 10.1016/s0959-8049(05)80203-5. Eur J Cancer. 1993. PMID: 8499150

3

Heterologous double-determinant immunoradiometric assay CA 125 II: reliable second-generation immunoassay for determining CA 125 in serum.

Kenemans P, van Kamp GJ, Oehr P, Verstraeten RA. Kenemans P, et al. Among authors: verstraeten ra. Clin Chem. 1993 Dec;39(12):2509-13. Clin Chem. 1993. PMID: 8252723

4

Multicenter evaluation of the Abbott IMx CA 15-3 assay.

van Kamp GJ, Bon GG, Verstraeten RA, Lynch D, Krikau M, Flückiger J, Ruibal A, Kenemans P. van Kamp GJ, et al. Among authors: verstraeten ra. Clin Chem. 1996 Jan;42(1):28-33. Clin Chem. 1996. PMID: 8565228

5

Clinical evaluation of the Byk LIA-mat CA125 II assay: discussion of a reference value.

Bonfrer JM, Korse CM, Verstraeten RA, van Kamp GJ, Hart GA, Kenemans P. Bonfrer JM, et al. Among authors: verstraeten ra. Clin Chem. 1997 Mar;43(3):491-7. Clin Chem. 1997. PMID: 9068593

6

Clinical and technical evaluation of ACS BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays.

Bon GG, von Mensdorff-Pouilly S, Kenemans P, van Kamp GJ, Verstraeten RA, Hilgers J, Meijer S, Vermorken JB. Bon GG, et al. Among authors: verstraeten ra. Clin Chem. 1997 Apr;43(4):585-93. Clin Chem. 1997. PMID: 9105258

7

Comparison of seven immunoassays for the quantification of CA 125 antigen in serum.

Davelaar EM, van Kamp GJ, Verstraeten RA, Kenemans P. Davelaar EM, et al. Among authors: verstraeten ra. Clin Chem. 1998 Jul;44(7):1417-22. Clin Chem. 1998. PMID: 9665418

8

The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass.

Schutter EM, Davelaar EM, van Kamp GJ, Verstraeten RA, Kenemans P, Verheijen RH. Schutter EM, et al. Am J Obstet Gynecol. 2002 Aug;187(2):385-92. doi: 10.1067/mob.2002.123768. Am J Obstet Gynecol. 2002. PMID: 12193930

9

Clinical and technical evaluation of the ACS:OV serum assay and comparison with three other CA125-detecting assays.

Davelaar EM, Schutter EM, von Mensdorff-Pouilly S, van Kamp GJ, Verstraeten RA, Kenemans P. Davelaar EM, et al. Ann Clin Biochem. 2003 Nov;40(Pt 6):663-73. doi: 10.1258/000456303770367270. Ann Clin Biochem. 2003. PMID: 14629806

10

Serum tumor marker immunoassays in gynecologic oncology: establishment of reference values.

Bon GG, Kenemans P, Verstraeten R, van Kamp GJ, Hilgers J. Bon GG, et al. Among authors: verstraeten r. Am J Obstet Gynecol. 1996 Jan;174(1 Pt 1):107-14. doi: 10.1016/s0002-9378(96)70381-2. Am J Obstet Gynecol. 1996. PMID: 8571992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters